Zhuhai Rundu Pharmaceutical Balance Sheet Health
Financial Health criteria checks 5/6
Zhuhai Rundu Pharmaceutical has a total shareholder equity of CN¥1.2B and total debt of CN¥494.4M, which brings its debt-to-equity ratio to 41.9%. Its total assets and total liabilities are CN¥2.2B and CN¥1.0B respectively. Zhuhai Rundu Pharmaceutical's EBIT is CN¥142.6M making its interest coverage ratio 10.3. It has cash and short-term investments of CN¥213.9M.
Key information
41.9%
Debt to equity ratio
CN¥494.41m
Debt
Interest coverage ratio | 10.3x |
Cash | CN¥213.91m |
Equity | CN¥1.18b |
Total liabilities | CN¥1.05b |
Total assets | CN¥2.23b |
Recent financial health updates
No updates
Recent updates
Zhuhai Rundu Pharmaceutical's (SZSE:002923) Dividend Is Being Reduced To CN¥0.20
May 29There May Be Reason For Hope In Zhuhai Rundu Pharmaceutical's (SZSE:002923) Disappointing Earnings
May 05There's Reason For Concern Over Zhuhai Rundu Pharmaceutical Co., Ltd.'s (SZSE:002923) Massive 32% Price Jump
Mar 05Financial Position Analysis
Short Term Liabilities: 002923's short term assets (CN¥866.7M) exceed its short term liabilities (CN¥446.3M).
Long Term Liabilities: 002923's short term assets (CN¥866.7M) exceed its long term liabilities (CN¥602.3M).
Debt to Equity History and Analysis
Debt Level: 002923's net debt to equity ratio (23.8%) is considered satisfactory.
Reducing Debt: 002923's debt to equity ratio has increased from 5.4% to 41.9% over the past 5 years.
Debt Coverage: 002923's debt is well covered by operating cash flow (34.9%).
Interest Coverage: 002923's interest payments on its debt are well covered by EBIT (10.3x coverage).